Skip to main content
Methodology
Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasis
- Chris Cameron,
- Brian Hutton,
- Cheryl Druchok,
- Sean McElligott,
- Sandhya Nair,
- Agata Schubert,
- Aaron Situ,
- Abhishek Varu, and
- Reggie Villacorta
pp1037–1051
Published Online:2 October 2018
Research Article
Mortality and healthcare costs in Medicare beneficiaries with AL amyloidosis
- Tiffany P Quock,
- Eunice Chang,
- Jennifer S Munday,
- Anita D'Souza,
- Sohum Gokhale, and
- Tingjian Yan
pp1053–1062
Published Online:25 October 2018
Patient characteristics and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban or vitamin K antagonists: real-world evidence from Italian administrative databases
- Sreeram Ramagopalan,
- Victoria Allan,
- Stefania Saragoni,
- Luca Degli Esposti,
- Davide Alessandrini,
- Valentina Perrone,
- Stefano Buda,
- Gillian Stynes,
- Caterina Toma,
- Francesco DeSolda, and
- on behalf of a LHUs group
pp1063–1071
Published Online:13 August 2018
Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record data
- Joshua J Gagne,
- Theodore Tsacogianis,
- Sara Bruce Wirta,
- James R Rogers,
- Frederico Calado,
- Chun-Lan Chang,
- Stuart J Turner,
- Raymond G Schlienger,
- Bogdan Balas,
- Abdurrahman Abdurrob,
- Mehdi Najafzadeh, and
- Shirley V Wang
pp1073–1082
Published Online:29 August 2018
Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder
- Tingjian Yan,
- Mallik Greene,
- Eunice Chang,
- Maëlys Touya, and
- Michael S Broder
pp1083–1093
Published Online:21 August 2018
Real-world assessment of treatment with extended-release topiramate (Trokendi XR®) and comparison with previous immediate-release topiramate treatment
- Welton O'Neal,
- Elizabeth E Hur,
- Tesfaye Liranso, and
- Barry Patel
pp1095–1105
Published Online:23 August 2018
Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis
- Iain B McInnes,
- Peter Nash,
- Christopher Ritchlin,
- Ernest H Choy,
- Steve Kanters,
- Howard Thom,
- Kunal Gandhi,
- Luminita Pricop, and
- Steffen M Jugl
pp1107–1123
Published Online:19 September 2018
The economic and humanistic burden of patients in receipt of current available therapies for nAMD
- Dena H Jaffe,
- Wing Chan,
- Vladimir Bezlyak, and
- Adrian Skelly
pp1125–1132
Published Online:21 September 2018